Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gertjan Beheydt

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
BMC Bioinformatics|August 5, 2010
Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscapeKristof Theys, Koen Deforche, Gertjan Beheydt, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 18, 2012
High frequency of antiviral drug resistance and non-B subtypes in HIV-1 patients failing antiviral therapy in CubaVivian Kourí, Yoan Alemán, Lissette Pérez, et al.
The Journal of Antimicrobial Chemotherapy|May 21, 2013
Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a first-line lopinavir/ritonavir-containing regimenClaudia Alteri, Anna Artese, Gertjan Beheydt, et al.
Plos One|April 25, 2013
Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy responseJurgen Vercauteren, Gertjan Beheydt, Mattia Prosperi, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|February 19, 2013
Antiretroviral drug resistance in HIV-1 therapy-naive patients in CubaLissette Pérez, Vivian Kourí, Yoan Alemán, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|March 26, 2013
HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failureRaphael Z Sangeda, Kristof Theys, Gertjan Beheydt, et al.
Bioinformatics (Oxford, England)|May 7, 2013
RegaDB: community-driven data management and analysis for infectious diseasesPieter Libin, Gertjan Beheydt, Koen Deforche, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
BMC Bioinformatics|August 5, 2010
Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscapeKristof Theys, Koen Deforche, Gertjan Beheydt, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 18, 2012
High frequency of antiviral drug resistance and non-B subtypes in HIV-1 patients failing antiviral therapy in CubaVivian Kourí, Yoan Alemán, Lissette Pérez, et al.
The Journal of Antimicrobial Chemotherapy|May 21, 2013
Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a first-line lopinavir/ritonavir-containing regimenClaudia Alteri, Anna Artese, Gertjan Beheydt, et al.
Plos One|April 25, 2013
Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy responseJurgen Vercauteren, Gertjan Beheydt, Mattia Prosperi, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|February 19, 2013
Antiretroviral drug resistance in HIV-1 therapy-naive patients in CubaLissette Pérez, Vivian Kourí, Yoan Alemán, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|March 26, 2013
HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failureRaphael Z Sangeda, Kristof Theys, Gertjan Beheydt, et al.
Bioinformatics (Oxford, England)|May 7, 2013
RegaDB: community-driven data management and analysis for infectious diseasesPieter Libin, Gertjan Beheydt, Koen Deforche, et al.
Pageof 1